0
Buy Cagrilintide online : an innovative solution for weight and diabetes control
Our online store offers Cagrilintide for sale — a modern drug, designed to reduce body weight and improve glycaemic control in patients with diabetes. It can be used as a standalone treatment or combined with glucagon-like peptide-based drugs (semaglutide, tirzepatide, retratide) to enhance their effect.
Pharmacological properties
Cagrilintide is a long-acting analogue of amylin, a pancreatic hormone that regulates appetite and slows gastric emptying. Natural amylin breaks down quickly, limiting its use, but cagrilintide, thanks to its modified structure, acts longer and more stably.
Its key effects:
creates a lasting feeling of satiety and reduces appetite;
slows down the digestion process;
affects the brain centres that control appetite;
promotes weight loss and improves glycaemic profile.
Where it is used
The drug is prescribed for the following conditions:
eating disorders and appetite control;
improved glycaemic control in type 1 and type 2 diabetes (in combination with diet and physical activity);
reduced risk of adverse cardiovascular events in diabetes;
obesity treatment and fat reduction;
enhancement of the action of GLP-1 and GIP receptor agonists (semaglutide, tirzepatide, etc.).
Clinical studies
A multicentre, double-blind, phase 2 study involving patients with type 2 diabetes and elevated body mass index showed:
combination of cagrilintide (1.2 mg) and semaglutide (1.2 mg) reduces glycated haemoglobin (HbA1c) levels by 2.2%, body weight by 15.6% and fasting plasma glucose levels by 3.3 mmol/L;
semaglutide 2.4 mg in monotherapy reduces HbA1c by 1.8% and body weight by 5.1%;
cagrilintide 2.4 mg in monotherapy reduces HbA1c by 0.9% and body weight by 8.1%.
The conclusion is obvious: combined use provides a pronounced synergistic effect, but the independent use of cagrilintid also demonstrates high effectiveness.
Who is it suitable for:
people who are overweight without serious metabolic disorders;
patients with type 2 diabetes — before starting therapy with GLP-1 agonists or in parallel with them;
patients with type 1 diabetes for whom GLP-1 agonists are contraindicated.
Side effects and contraindications
Possible symptoms: loss of appetite, nausea, constipation, diarrhoea, feeling of a full stomach. These symptoms are usually mild and temporary.
The drug is contraindicated in:
family or personal history of medullary thyroid cancer;
type 2 multiple endocrine neoplasia syndrome;
severe hypersensitivity;
intestinal obstruction;
frequent gastroesophageal reflux.
Before starting the course, it is necessary to consult a doctor.
How to take cagrilintide:
starting dose — 1 mg subcutaneously once a week;
from the 2nd week, the dose can be increased to 2 mg;
further, the dosage is increased by 1 mg every week if it is necessary to strengthen appetite control;
maximum weekly dose — 6 mg;
a missed injection can be given within 5 days;
administered subcutaneously in the abdomen, thigh or shoulder, changing the injection site each time.
The drug is not mixed with insulin and requires separate administration.
Why you should order Cagrilintide from us:
original product;
convenient form of release;
delivery worldwide;
professional consultation with specialists.
Cagrilintide is a modern tool for controlling appetite, body weight and sugar levels. It opens up new possibilities in the treatment of obesity and diabetes.
Before use, be sure to consult your doctor and familiarise yourself with the contraindications. The appearance of the packaging may be changed by the manufacturer without prior notice.